Cargando…
RPP30 is a novel diagnostic and prognostic biomarker for gastric cancer
Objective: This study aimed to identify the hub gene in gastric cancer (GC) tumorigenesis. A biomarker prediction model was constructed and analyzed, and protein expression in histopathological samples was verified in a validation cohort. Methods: Differentially expressed genes (DEGs) were identifie...
Autores principales: | Kan, Ying, Lu, Xia, Feng, Lijuan, Yang, Xu, Ma, Huan, Gong, Jianhua, Yang, Jigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343801/ https://www.ncbi.nlm.nih.gov/pubmed/35928448 http://dx.doi.org/10.3389/fgene.2022.888051 |
Ejemplares similares
-
RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma
por: Xiao, Dongdong, et al.
Publicado: (2022) -
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2020) -
Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis
por: Niu, Xiaoji, et al.
Publicado: (2022) -
RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022) -
Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer
por: Yang, Shifeng, et al.
Publicado: (2022)